AREXVY
Live / Registered — Registered (as of 15 Nov 2022)
What this means for you
Registered since 15 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97052261
- Registration number
- 6899018
- Mark type
- Stylized text
- Filed
- 29 Sept 2021
- Published for opposition
- 30 Aug 2022
- Registered
- 15 Nov 2022
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 15 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Aug 2022 — PUBLISHED FOR OPPOSITION
- 10 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 02 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jul 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jul 2022 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 22 Jul 2022 — ASSIGNED TO LIE
- 05 Jul 2022 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 29 Jun 2022 — ASSIGNED TO EXAMINER
- 27 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED